The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 03, 2020

Filed:

Sep. 25, 2017
Applicant:

The Procter & Gamble Company, Cincinnati, OH (US);

Inventors:

Mark Edward Stella, Cincinnati, OH (US);

John Richard Entwisle, Mason, OH (US);

Baltej Ludher, Cincinnati, OH (US);

Jonathan E. Clark, Loveland, OH (US);

Daren K. Aness, Loveland, OH (US);

Guhan Balan, Mason, OH (US);

Andrew Nicholas Carr, Maineville, OH (US);

Assignee:

The Procter & Gamble Company, Cincinnati, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 9/00 (2006.01); A61K 31/137 (2006.01); A61K 31/485 (2006.01); A61K 9/24 (2006.01); A61K 9/48 (2006.01); A61K 31/192 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2086 (2013.01); A61K 9/0002 (2013.01); A61K 9/2004 (2013.01); A61K 9/209 (2013.01); A61K 9/2054 (2013.01); A61K 9/2095 (2013.01); A61K 9/4808 (2013.01); A61K 31/137 (2013.01); A61K 31/192 (2013.01); A61K 31/485 (2013.01); A61K 2300/00 (2013.01);
Abstract

A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.


Find Patent Forward Citations

Loading…